Sector ratings Caplin Point Laboratories Limited

Stocks

Delayed Bombay S.E. Other stock markets 01:50:18 2026-08-12 EDT			5-day change	1st Jan Change
2,614.60 ^INR	-0.36%		+2.81%	+42.01%

05-14	Caplin Point Laboratories Limited, Q4 2026 Earnings Call, May 14, 2026
05-14	Caplin Point Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Visibility	Consensus
CAPLIN POINT LABORATORIES LIMITED	2.09B	-	-	-		-
SUN PHARMACEUTICAL INDUSTRIES LTD.	48.85B		B
OTSUKA HOLDINGS CO., LTD.	41.43B		A
CIPLA LIMITED	12.39B		A
ZYDUS LIFESCIENCES LIMITED	12.46B		BB
KRKA, D. D.	9.08B		-
GEDEON RICHTER	7.53B		A
ONO PHARMACEUTICAL CO., LTD.	7.14B		AA
GLENMARK PHARMACEUTICALS LIMITED	6.73B		BB
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.	5.88B	-	BB	-		-	-
AJANTA PHARMA LIMITED	4.59B		BB
ASPEN PHARMACARE HOLDINGS LIMITED	4.02B		A
SIMCERE PHARMACEUTICAL GROUP LIMITED	4.04B		A
WOCKHARDT LIMITED	3.25B	-	BB	-	-	-	-	-
SAM CHUN DANG PHARM. CO., LTD	3.18B	-	CCC	-	-	-	-	-
ASTRA INDUSTRIAL GROUP COMPANY	2.94B		CCC				-
HAW PAR CORPORATION LIMITED	2.76B	-	-	-		-	-
SUNSHINE LAKE PHARMA CO., LTD.	2.63B	-	B	-	-	-	-
JAMJOOM PHARMACEUTICALS FACTORY COMPANY	2.62B		B	-
APICHOPE PHARMACEUTICAL GROUP CO., LTD.	2.46B	-	-	-		-	-
Average	9.3B		BBB
Weighted average by Cap.			BBB